Partager

Latest Documents


  • 29-November-2018

    English

    Pharmaceutical Innovation and Access to Medicines

    This report reviews the important role of medicines in health systems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing. It then highlights current issues for policy makers, such as the increasing prices of new medicines; concerns about the value of spending in some therapeutic areas; challenges in anticipating the arrival of very effective medicines for highly prevalent diseases; sharp price increases in off-patent products; and the apparent misalignment of current incentives for the development of treatments for certain conditions. The report also describes the role of the biopharmaceutical industry in OECD economies, examines the process of pharmaceutical R&D and its financing, and looks at the risks, costs and return from R&D investment for the industry. Examining trends in the industry over time, it shows that productivity of R&D expenditure has declined; that the duration of market exclusivity has remained relatively stable; that new medicines are increasingly being developed for small patient populations; and that the industry as a whole has remained highly profitable for investors. Lastly, the report presents a range of policy options for consideration by policy makers, to support the development of effective and co-ordinated responses to the identified challenges.
  • 22-November-2018

    English, PDF, 2,328kb

    Health at a Glance: Europe 2018 - Chartset

    Access key results from "Health at a Glance: Europe 2018" in this chartset.

    Related Documents
  • 22-novembre-2018

    Français, PDF, 1,202kb

    Panorama de la santé : Europe 2018 - Chartset

    Présentation en français sur les résultats clés issus du Panorama de la santé : Europe 2018.

    Documents connexes
  • 22-November-2018

    English

    Health at a Glance: Europe 2018 - State of Health in the EU Cycle

    Health at a Glance: Europe 2018 presents comparative analyses of the health status of EU citizens and the performance of the health systems of the 28 EU Member States, 5 candidate countries and 3 EFTA countries. It is the first step in the State of Health in the EU cycle of knowledge brokering. This publication has two parts. Part I comprises two thematic chapters, the first focusing on the need for concerted efforts to promote better mental health, the second outlining possible strategies for reducing wasteful spending in health. In Part II, the most recent trends in key indicators of health status, risk factors and health spending are presented, together with a discussion of progress in improving the effectiveness, accessibility and resilience of European health systems.
  • 7-November-2018

    English

    Stemming the Superbug Tide - Just A Few Dollars More

    Antimicrobial resistance (AMR) is a large and growing problem with the potential for enormous health and economic consequences, globally. As such, AMR has become a central issue at the top of the public health agenda of OECD countries and beyond. In this report, OECD used advanced techniques, including machine learning, ensemble modelling and a microsimulation model, to provide support for policy action in the human health sector. AMR rates are high and are projected to grow further, particularly for second- and third-line antibiotics, and if no effective action is taken this is forecasted to produce a significant health and economic burden in OECD and EU28 countries. This burden can be addressed by implementing effective public health initiatives. This report reviews policies currently in place in high-income countries and identifies a set of ‘best buys’ to tackle AMR that, if scaled up at the national level, would provide an affordable and cost-effective instrument in the fight against AMR.
  • 7-November-2018

    English, PDF, 2,366kb

    Stemming the Superbug Tide - Policy Brief

    This Policy Brief gives an insight to key messages and various highlights from the new OECD report "Stemming the Superbug Tide: Just a Few Dollars More", which analyses the impact of antimicrobial resistance (AMR). The report, based on new forecasts of the growth in resistance to 2050, outlines how countries can tackle AMR and significantly reduce the personal and economic costs.

    Related Documents
  • 26-October-2018

    English

    Pharmaceutical Pricing Policy project

    The OECD Pharmaceutical Pricing Policy project had two main objectives: to add to the base of information about pharmaceutical pricing policy in OECD countries and develop a taxonomy and framework for making international comparisons of policies, and to analyse cross-national impacts and implications of policies, particularly with respect to the impacts on pharmaceutical prices paid in other countries and on pharmaceutical R&D.

    Related Documents
  • 26-October-2018

    English

    Long-term Care

    With populations in OECD countries ageing, more people are living with long-term care needs. The OECD Health Division has an ongoing programme of work to support countries in developing long-term care systems that can meet the needs of their populations now and in the future.

  • 9-October-2018

    English, PDF, 6,170kb

    Children & Young People’s Mental Health in the Digital Age - Shaping the Future

    Being online and using social media are an integral part of children and young people's lives. There are concerns that reliance on digital technologies and social media exacerbates feelings of anxiety, depression, disturbing sleep patterns, leading to cyber-bullying and distorting body image. It is crucial to adopt an approach that minimises the risks without restricting the opportunities digital technologies and social media can offer.

    Related Documents
  • 9-October-2018

    English, PDF, 634kb

    Mental Health Facts and Figures

    Mental Health Facts and Figures

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>